Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02265536
Title A Study of LY3022855 In Participants With Breast or Prostate Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

breast cancer

prostate cancer

Therapies

LY3022855

Age Groups: adult
Covered Countries USA


No variant requirements are available.